These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23647679)

  • 1. Retaining cytotoxic activity of anthrapyridone CO1 against multidrug resistant cells is related to the ability to induce concomitantly apoptosis and lysosomal death of leukaemia HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    J Pharm Pharmacol; 2013 Jun; 65(6):855-67. PubMed ID: 23647679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthraquinone antitumour agents, doxorubicin, pirarubicin and benzoperimidine BP1, trigger caspase-3/caspase-8-dependent apoptosis of leukaemia sensitive HL60 and resistant HL60/VINC and HL60/DOX cells.
    Nowak R; Tarasiuk J
    Anticancer Drugs; 2012 Apr; 23(4):380-92. PubMed ID: 22198116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioreductive Activation of Antitumour Drugs, Doxorubicin and Pirarubicin, Does Not Affect Their Ability to Induce Apoptosis of Sensitive and Multidrug Resistant Leukaemia HL60 Cells.
    Kostrzewa-Nowak D; Tarasiuk J
    Anticancer Res; 2021 Mar; 41(3):1429-1438. PubMed ID: 33788734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase does not change its apoptotic stimuli properties in regard to sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Tarasiuk J
    Eur J Pharmacol; 2013 Dec; 721(1-3):141-50. PubMed ID: 24076328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of selected pyridinium salts to increase the cytotoxic activity of vincristine but not doxorubicin towards sensitive and multidrug resistant promyelocytic leukaemia HL60 cells.
    Maruszewska A; Kostrzewa-Nowak D; Adamus J; Czupryńska K; Maryniak D; Gebicki J; Tarasiuk J
    J Pharm Pharmacol; 2008 May; 60(5):647-53. PubMed ID: 18416942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of structural factors of antitumour anthraquinone derivatives and analogues in the ability to undergo bioreductive activation by NADPH cytochrome P450 reductase: implications for increasing the activity against sensitive and multidrug-resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
    Anticancer Drugs; 2012 Apr; 23(4):393-405. PubMed ID: 22205152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.
    Kostrzewa-Nowak D; Paine MJ; Wolf CR; Tarasiuk J
    Br J Cancer; 2005 Jul; 93(1):89-97. PubMed ID: 15942634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour effects of selected plant polyphenols, gallic acid and ellagic acid, on sensitive and multidrug-resistant leukaemia HL60 cells.
    Maruszewska A; Tarasiuk J
    Phytother Res; 2019 Apr; 33(4):1208-1221. PubMed ID: 30838722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin Triggers Induction of Apoptotic and Lysosomal Death of Sensitive and Multidrug Resistant Leukaemia HL60 Cells.
    Maruszewska A; Tarasiuk J
    Nutr Cancer; 2021; 73(3):484-501. PubMed ID: 32329631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour Effects of Selected Pyridinium Salts on Sensitive Leukaemia HL60 Cells and Their Multidrug Resistant Topoisomerase II-Defective HL60/MX2 Counterparts.
    Tarasiuk J; Kostrzewa-Nowak D; Żwierełło W
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
    Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
    Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bioreductive activation of antitumour anthracycline drugs in cytotoxic activity against sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Bieg B; Paine MJ; Wolf CR; Tarasiuk J
    Eur J Pharmacol; 2012 Jan; 674(2-3):112-25. PubMed ID: 22115891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.
    Łubgan D; Jóźwiak Z; Grabenbauer GG; Distel LV
    Cell Mol Biol Lett; 2009; 14(1):113-27. PubMed ID: 18850074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
    Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
    Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-Sensitive Peptide-Conjugated Doxorubicin Mediates the Lysosomal Pathway of Apoptosis and Reverses Drug Resistance in Breast Cancer.
    Sheng Y; Xu J; You Y; Xu F; Chen Y
    Mol Pharm; 2015 Jul; 12(7):2217-28. PubMed ID: 26035464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells.
    Kostrzewa-Nowak D; Paine MJ; Korytowska A; Serwatka K; Piotrowska S; Wolf CR; Tarasiuk J
    Cancer Lett; 2007 Jan; 245(1-2):252-62. PubMed ID: 16574318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pro-apoptotic activity of doxorubicin-transferrin conjugate in cells derived from human solid tumors.
    Szwed M; Kania KD; Jozwiak Z
    Int J Biochem Cell Biol; 2016 Jan; 70():57-67. PubMed ID: 26520467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF.
    Kim BM; Choi YJ; Lee YH; Joe YA; Hong SH
    Apoptosis; 2010 Aug; 15(8):982-93. PubMed ID: 20512627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.